cystamine has been researched along with B16 Melanoma in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Growth of transplanted B16 melanoma was suppressed effectively by NPrCAP/M-mediated hyperthermia, suggesting a clinical application of NPrCAP/M to lesional therapy for melanoma." | 1.35 | N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells. ( Honda, H; Ito, A; Ito, S; Jimbow, K; Matsusaka, H; Ohkura, M; Ono, I; Osai, Y; Sasaki, Y; Sato, A; Sato, M; Sato, N; Takada, T; Tamura, Y; Wakamatsu, K; Yamashita, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, M | 2 |
| Yamashita, T | 4 |
| Ohkura, M | 1 |
| Osai, Y | 2 |
| Sato, A | 2 |
| Takada, T | 2 |
| Matsusaka, H | 1 |
| Ono, I | 2 |
| Tamura, Y | 4 |
| Sato, N | 3 |
| Sasaki, Y | 1 |
| Ito, A | 4 |
| Honda, H | 4 |
| Wakamatsu, K | 4 |
| Ito, S | 4 |
| Jimbow, K | 5 |
| Okura, M | 2 |
| Ishii-Osai, Y | 2 |
| Nakayama, E | 2 |
| Nishigaki, A | 1 |
| Ojika, M | 1 |
| Tandon, M | 1 |
| Thomas, PD | 1 |
| Shokravi, M | 1 |
| Singh, S | 1 |
| Samra, S | 1 |
| Chang, D | 1 |
5 other studies available for cystamine and B16 Melanoma
| Article | Year |
|---|---|
N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cystamine; Female; Ferrosoferric Oxide; Humans; Hypertherm | 2009 |
Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.
Topics: Animals; Cell Line, Tumor; Cross-Priming; Cystamine; Cytotoxicity, Immunologic; Dendritic Cells; Ele | 2010 |
N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
Topics: Animals; Antibodies; Antineoplastic Agents; Apoptosis; Caspase 3; CD4-Positive T-Lymphocytes; CD8-Po | 2012 |
Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.
Topics: Animals; Antigens, Neoplasm; Chromatography, High Pressure Liquid; Cystamine; Magnetic Resonance Spe | 2012 |
Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.
Topics: Animals; Antineoplastic Agents; Cystamine; Cysteamine; Humans; Hypopigmentation; Melanins; Melanoma, | 1998 |